CRISPR

98 Articles
Created: 2026/05/29 16:29
Updated: 2026/05/29 16:29
Cathie Wood may have timed her Elon Musk bet just right

Cathie Wood may have timed her Elon Musk bet just right

Cathie Wood’s early SpaceX bet gained attention after Elon Musk’s IPO

Author: Thestreet
Wall Street Watch: SpaceX, Quantum Stocks, and GameStop (GME) Dominate Headlines

Wall Street Watch: SpaceX, Quantum Stocks, and GameStop (GME) Dominate Headlines

SpaceX-Google space talks, quantum computing momentum, AeroVironment defense win, GameStop's rejected eBay bid, and Cathie Wood's ARKK holdings explained. The post

Author: Blockonomi
Today’s Top Stories: AeroVironment, GameStop, and Google Lead a Wild Day on Wall Street

Today’s Top Stories: AeroVironment, GameStop, and Google Lead a Wild Day on Wall Street

TLDR Google and SpaceX are in talks to use rocket launches to support orbital data centers tied to Project Suncatcher Quantum computing stocks QUBT, RGTI, and QBTS

Author: Coincentral
Inside Cathie Wood’s ARK Innovation ETF: Tesla (TSLA), Coinbase, and AMD Lead the Pack

Inside Cathie Wood’s ARK Innovation ETF: Tesla (TSLA), Coinbase, and AMD Lead the Pack

Cathie Wood's ARKK ETF features Tesla, AMD, Coinbase, and CRISPR Therapeutics as top holdings. Discover the fund's focus on AI, crypto, and genomics. The post Inside

Author: Blockonomi
Cathie Wood Is Still Betting Big on Tesla, Coinbase and AMD — Here’s Her Main Portfolio

Cathie Wood Is Still Betting Big on Tesla, Coinbase and AMD — Here’s Her Main Portfolio

TLDR Tesla is ARKK’s top holding at 10.46%, followed by AMD at 5.66% The fund holds 46 stocks, with the top 10 making up just over 51% of the portfolio Coinbase

Author: Coincentral
Ark Invest Buys $5.5M in Circle Shares as CRCL Stock Rises After Q1 Earnings

Ark Invest Buys $5.5M in Circle Shares as CRCL Stock Rises After Q1 Earnings

TLDR Ark Invest bought 41,904 Circle shares worth about $5.5M across three ETFs. Circle stock closed up 15.91% at $131.76 after its Q1 earnings release. Circle

Author: Coincentral
Eli Lilly (LLY) Stock; Edges Higher as $2.25B AI Gene-Editing Deal Sparks Biotech Optimism

Eli Lilly (LLY) Stock; Edges Higher as $2.25B AI Gene-Editing Deal Sparks Biotech Optimism

TLDRs; Eli Lilly stock rose slightly after announcing a $2.25 billion AI gene-editing partnership with Profluent. Deal focuses on AI-designed recombinase proteins

Author: Coincentral
Crispr gene editing treatment from Intellia succeeds in Phase 3 trial

Crispr gene editing treatment from Intellia succeeds in Phase 3 trial

The post Crispr gene editing treatment from Intellia succeeds in Phase 3 trial appeared on BitcoinEthereumNews.com. Intellia Therapeutics, building exterior and

Author: BitcoinEthereumNews
The third-quarter reports of 11 Wall Street financial giants revealed a "major divergence": some liquidated their technology and crypto holdings while others increased their investments.

The third-quarter reports of 11 Wall Street financial giants revealed a "major divergence": some liquidated their technology and crypto holdings while others increased their investments.

Author: Nancy, PANews US stocks are undoubtedly the main battleground with the most abundant global liquidity, especially technology stocks led by Nvidia, which

Author: PANews
Cathie Wood Dumps Tech Stocks for Gene-Editing Plays in CRISPR and Beam

Cathie Wood Dumps Tech Stocks for Gene-Editing Plays in CRISPR and Beam

The post Cathie Wood Dumps Tech Stocks for Gene-Editing Plays in CRISPR and Beam appeared on BitcoinEthereumNews.com. TLDR Cathie Wood’s ARK Invest purchased $10

Author: BitcoinEthereumNews